Statement from the REMAP-CAP trial: International Trials of Blood Thinners Pause Enrolment of Critically Ill COVID-19 Patients Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrolment for one group of patients. Among critically ill COVID-19 patients requiring intensive care unit (ICU) support, […]
Statement from the REMAP-CAP trial
